{"id":17281,"date":"2020-07-20T11:37:29","date_gmt":"2020-07-20T09:37:29","guid":{"rendered":"https:\/\/www.anicecommunication.com\/it\/?p=17281"},"modified":"2021-06-21T15:00:22","modified_gmt":"2021-06-21T13:00:22","slug":"covid-19-e-mieloma-multiplo","status":"publish","type":"post","link":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/","title":{"rendered":"COVID-19 E MIELOMA MULTIPLO"},"content":{"rendered":"<h4><b>Covid-19 e Mieloma Multiplo: la<\/b><\/h4>\n<p><!--more--><\/p>\n<h4><b><a href=\"https:\/\/www.emnitaly.org\/it-IT\/home\">Fondazione EMN Italy Onlus di Torino<\/a>, in collaborazione con European Myeloma Network International, ha avviato uno studio osservazionale nei pazienti affetti da Mieloma Multiplo e Covid-19 che coinvolger\u00e0 7 stati Europei pi\u00f9 il Regno Unito.<\/b><\/h4>\n<p class=\"text-justify\"><b>Torino, 20 luglio 2020<\/b> \u2013\u00a0La Fondazione EMN Italy Onlus, realt\u00e0 italiana d\u2019eccellenza impegnata nella ricerca clinica e scientifica e nel supporto ai pazienti affetti da Mieloma Multiplo, in questi difficili mesi di emergenza Covid-19 ha intensificato il suo impegno verso questi soggetti pi\u00f9 fragili e ha avviato, in collaborazione con EMN &#8211; European Myeloma Network International, <strong>un\u2019iniziativa di raccolta dati (studio osservazionale) a livello europeo nei pazienti con mieloma che hanno contratto l\u2019infezione da Covid-19.<\/strong><\/p>\n<p class=\"text-justify\">Gli <strong>obiettivi <\/strong>di questa ricerca sono, oltre a definire come si comporta il virus Covid-19 nei pazienti con mieloma, stabilire la severit\u00e0 della malattia, i risvolti clinici e l\u2019eventuale impatto della terapia antitumorale. Verranno individuati i valori di laboratorio associati alla malattia e saranno analizzate eventuali connessioni con conseguente rischio di peggioramento della situazione clinica. Saranno delineati possibili sottogruppi di pazienti in cui si \u00e8 riscontrata una maggiore incidenza del virus e si valuteranno le diverse risposte cliniche. Lo studio sar\u00e0 anche volto a comprendere quanto il <i>Myeloma Frailty Score<\/i>, ovvero l\u2019indice di fragilit\u00e0 assegnato a ciascun paziente affetto da Mieloma Multiplo, abbia avuto un ruolo nel delineare i pazienti a maggior rischio e verr\u00e0 valutato se le diverse strategie adottate dai singoli paesi abbiano in qualche modo contribuito a diversi scenari e risvolti clinici.<\/p>\n<p><img decoding=\"async\" class=\"aligncenter size-full wp-image-17282\" src=\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg\" alt=\"Covid-19 e Mieloma Multiplo\" width=\"600\" height=\"400\" srcset=\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN-200x133.jpg 200w, https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN-300x200.jpg 300w, https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN-400x267.jpg 400w, https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg 600w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/p>\n<p>Lo studio coinvolger\u00e0, infatti, <strong>7 stati europei (Italia, Olanda, Austria, Repubblica Ceca, Belgio, Germania e Grecia) pi\u00f9 il Regno Unito<\/strong> con il Prof. Gordon Cook, ematologo e docente presso l&#8217;universit\u00e0 di Leeds nonch\u00e9 membro del board di EMN International, coordinatore dell\u2019intero progetto. <strong>La Fondazione EMN Italy Onlus svolge un ruolo fondamentale in questo studio internazionale perch\u00e9<\/strong><strong> \u00e8 proprio nella sede torinese della Fondazione che \u00e8 stata realizzata la piattaforma unica per la raccolta dati <\/strong>e anche perch\u00e9 <strong>sono gi\u00e0 due i centri attivi e pronti ad arruolare i pazienti<\/strong>: l\u2019IRCCS Ospedale Casa Sollievo della Sofferenza di San Giovanni Rotondo, in provincia di Foggia e la Fondazione IRCCS Istituto Nazionale dei Tumori di Milano.<\/p>\n<p><em><strong><a href=\"https:\/\/www.anicecommunication.com\/it\/agenzia-di-comunicazione\/\">Anicecommunication<\/a> &#8211; <a href=\"https:\/\/www.anicecommunication.com\/it\/media-relations\/\">Ufficio Stampa<\/a> Fondazione EMN Italy Onlus<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Covid-19 e Mieloma Multiplo: la<\/p>\n","protected":false},"author":1,"featured_media":17282,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602,59,66,467,80],"tags":[115,536,502,446],"class_list":["post-17281","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-emn","category-i_nostri_servizi","category-ufficio_stampa","category-press_room","category-blog-anicecommunication","tag-anicecommunication","tag-covid-19-e-mieloma-multiplo","tag-fondazione-emn-italy-onlus","tag-mieloma-multiplo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>COVID-19 E MIELOMA MULTIPLO - IT Anice Communication<\/title>\n<meta name=\"description\" content=\"Covid-19 e Mieloma Multiplo: la Fondazione EMN Italy Onlus Torino ha avviato uno studio osservazionale che coinvolger\u00e0 7 stati Europei pi\u00f9 il Regno Unito\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 E MIELOMA MULTIPLO - IT Anice Communication\" \/>\n<meta property=\"og:description\" content=\"Covid-19 e Mieloma Multiplo: la Fondazione EMN Italy Onlus Torino ha avviato uno studio osservazionale che coinvolger\u00e0 7 stati Europei pi\u00f9 il Regno Unito\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/\" \/>\n<meta property=\"og:site_name\" content=\"IT Anice Communication\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/anicecommunication\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/anicecommunication\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-20T09:37:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-21T13:00:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editorial Staff\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editorial Staff\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/\"},\"author\":{\"name\":\"Editorial Staff\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#\/schema\/person\/d8f9046f11c2ab1ff15f1d0d580184d8\"},\"headline\":\"COVID-19 E MIELOMA MULTIPLO\",\"datePublished\":\"2020-07-20T09:37:29+00:00\",\"dateModified\":\"2021-06-21T13:00:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/\"},\"wordCount\":376,\"publisher\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg\",\"keywords\":[\"Anicecommunication\",\"Covid-19 e Mieloma Multiplo\",\"Fondazione EMN Italy Onlus\",\"mieloma multiplo\"],\"articleSection\":[\"EMN\",\"I nostri servizi\",\"L'Ufficio Stampa\",\"Press Room\",\"What A Nice Blog!\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/\",\"url\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/\",\"name\":\"COVID-19 E MIELOMA MULTIPLO - IT Anice Communication\",\"isPartOf\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg\",\"datePublished\":\"2020-07-20T09:37:29+00:00\",\"dateModified\":\"2021-06-21T13:00:22+00:00\",\"description\":\"Covid-19 e Mieloma Multiplo: la Fondazione EMN Italy Onlus Torino ha avviato uno studio osservazionale che coinvolger\u00e0 7 stati Europei pi\u00f9 il Regno Unito\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#primaryimage\",\"url\":\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg\",\"contentUrl\":\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg\",\"width\":600,\"height\":400,\"caption\":\"Covid-19 e Mieloma Multiplo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.anicecommunication.com\/it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVID-19 E MIELOMA MULTIPLO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#website\",\"url\":\"https:\/\/www.anicecommunication.com\/it\/\",\"name\":\"IT Anice Communication\",\"description\":\"Anicecommunication agenzia di pubbliche relazioni,  ufficio stampa, media relations, automotive e mobility a livello internazionale - Torino\",\"publisher\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anicecommunication.com\/it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#organization\",\"name\":\"Anice SRL - Agenzia di comunicazione, mobility and automotive media relations & PR in Italia, Europa\",\"alternateName\":\"Anicecommunication\",\"url\":\"https:\/\/www.anicecommunication.com\/it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2023\/06\/Anice_696x696.jpg\",\"contentUrl\":\"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2023\/06\/Anice_696x696.jpg\",\"width\":696,\"height\":696,\"caption\":\"Anice SRL - Agenzia di comunicazione, mobility and automotive media relations & PR in Italia, Europa\"},\"image\":{\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/anicecommunication\",\"https:\/\/x.com\/Anicecom\",\"https:\/\/instagram.com\/anicecom\/\",\"https:\/\/www.linkedin.com\/company\/anice-s-r-l-\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#\/schema\/person\/d8f9046f11c2ab1ff15f1d0d580184d8\",\"name\":\"Editorial Staff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.anicecommunication.com\/it\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/62128a8e64953c282b330a12e5b592d8bc5d299b46ab0e6928129ae0d79e528a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/62128a8e64953c282b330a12e5b592d8bc5d299b46ab0e6928129ae0d79e528a?s=96&d=mm&r=g\",\"caption\":\"Editorial Staff\"},\"description\":\"La redazione di Anicecommunication \u00e8 composta da giornalisti, esperti di comunicazione e marketing, content manager e storyteller.\",\"sameAs\":[\"http:\/\/www.anicecommunication.com\",\"https:\/\/www.facebook.com\/anicecommunication\",\"https:\/\/x.com\/anicecom\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19 E MIELOMA MULTIPLO - IT Anice Communication","description":"Covid-19 e Mieloma Multiplo: la Fondazione EMN Italy Onlus Torino ha avviato uno studio osservazionale che coinvolger\u00e0 7 stati Europei pi\u00f9 il Regno Unito","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/","og_locale":"it_IT","og_type":"article","og_title":"COVID-19 E MIELOMA MULTIPLO - IT Anice Communication","og_description":"Covid-19 e Mieloma Multiplo: la Fondazione EMN Italy Onlus Torino ha avviato uno studio osservazionale che coinvolger\u00e0 7 stati Europei pi\u00f9 il Regno Unito","og_url":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/","og_site_name":"IT Anice Communication","article_publisher":"https:\/\/www.facebook.com\/anicecommunication","article_author":"https:\/\/www.facebook.com\/anicecommunication","article_published_time":"2020-07-20T09:37:29+00:00","article_modified_time":"2021-06-21T13:00:22+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg","type":"image\/jpeg"}],"author":"Editorial Staff","twitter_misc":{"Scritto da":"Editorial Staff","Tempo di lettura stimato":"2 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#article","isPartOf":{"@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/"},"author":{"name":"Editorial Staff","@id":"https:\/\/www.anicecommunication.com\/it\/#\/schema\/person\/d8f9046f11c2ab1ff15f1d0d580184d8"},"headline":"COVID-19 E MIELOMA MULTIPLO","datePublished":"2020-07-20T09:37:29+00:00","dateModified":"2021-06-21T13:00:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/"},"wordCount":376,"publisher":{"@id":"https:\/\/www.anicecommunication.com\/it\/#organization"},"image":{"@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg","keywords":["Anicecommunication","Covid-19 e Mieloma Multiplo","Fondazione EMN Italy Onlus","mieloma multiplo"],"articleSection":["EMN","I nostri servizi","L'Ufficio Stampa","Press Room","What A Nice Blog!"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/","url":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/","name":"COVID-19 E MIELOMA MULTIPLO - IT Anice Communication","isPartOf":{"@id":"https:\/\/www.anicecommunication.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#primaryimage"},"image":{"@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg","datePublished":"2020-07-20T09:37:29+00:00","dateModified":"2021-06-21T13:00:22+00:00","description":"Covid-19 e Mieloma Multiplo: la Fondazione EMN Italy Onlus Torino ha avviato uno studio osservazionale che coinvolger\u00e0 7 stati Europei pi\u00f9 il Regno Unito","breadcrumb":{"@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#primaryimage","url":"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg","contentUrl":"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2020\/07\/600px_200713_Covid_e_Mieloma_Multiplo_FondazioneEMN.jpg","width":600,"height":400,"caption":"Covid-19 e Mieloma Multiplo"},{"@type":"BreadcrumbList","@id":"https:\/\/www.anicecommunication.com\/it\/covid-19-e-mieloma-multiplo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.anicecommunication.com\/it\/"},{"@type":"ListItem","position":2,"name":"COVID-19 E MIELOMA MULTIPLO"}]},{"@type":"WebSite","@id":"https:\/\/www.anicecommunication.com\/it\/#website","url":"https:\/\/www.anicecommunication.com\/it\/","name":"IT Anice Communication","description":"Anicecommunication agenzia di pubbliche relazioni,  ufficio stampa, media relations, automotive e mobility a livello internazionale - Torino","publisher":{"@id":"https:\/\/www.anicecommunication.com\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anicecommunication.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.anicecommunication.com\/it\/#organization","name":"Anice SRL - Agenzia di comunicazione, mobility and automotive media relations & PR in Italia, Europa","alternateName":"Anicecommunication","url":"https:\/\/www.anicecommunication.com\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.anicecommunication.com\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2023\/06\/Anice_696x696.jpg","contentUrl":"https:\/\/www.anicecommunication.com\/it\/wp-content\/uploads\/sites\/3\/2023\/06\/Anice_696x696.jpg","width":696,"height":696,"caption":"Anice SRL - Agenzia di comunicazione, mobility and automotive media relations & PR in Italia, Europa"},"image":{"@id":"https:\/\/www.anicecommunication.com\/it\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/anicecommunication","https:\/\/x.com\/Anicecom","https:\/\/instagram.com\/anicecom\/","https:\/\/www.linkedin.com\/company\/anice-s-r-l-"]},{"@type":"Person","@id":"https:\/\/www.anicecommunication.com\/it\/#\/schema\/person\/d8f9046f11c2ab1ff15f1d0d580184d8","name":"Editorial Staff","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.anicecommunication.com\/it\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/62128a8e64953c282b330a12e5b592d8bc5d299b46ab0e6928129ae0d79e528a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/62128a8e64953c282b330a12e5b592d8bc5d299b46ab0e6928129ae0d79e528a?s=96&d=mm&r=g","caption":"Editorial Staff"},"description":"La redazione di Anicecommunication \u00e8 composta da giornalisti, esperti di comunicazione e marketing, content manager e storyteller.","sameAs":["http:\/\/www.anicecommunication.com","https:\/\/www.facebook.com\/anicecommunication","https:\/\/x.com\/anicecom"]}]}},"_links":{"self":[{"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/posts\/17281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/comments?post=17281"}],"version-history":[{"count":3,"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/posts\/17281\/revisions"}],"predecessor-version":[{"id":17287,"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/posts\/17281\/revisions\/17287"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/media\/17282"}],"wp:attachment":[{"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/media?parent=17281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/categories?post=17281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.anicecommunication.com\/it\/wp-json\/wp\/v2\/tags?post=17281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}